GW PHARMACEUTICALS PLC Balance Sheet

Ask AI

Financial Statements

In millions of USD, except per-share amounts

	Q1 FY2021 As of Mar 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q3 FY2020 As of Sep 30, 2020	Q2 FY2020 As of Jun 30, 2020	Q1 FY2020 As of Mar 31, 2020	Q4 FY2019 As of Dec 31, 2019	Q3 FY2019 As of Sep 30, 2019	Q2 FY2019 As of Jun 30, 2019	Q1 FY2019 As of Mar 31, 2019	Q3 FY2018 As of Sep 30, 2018
Assets
Cash and cash equivalents
Accounts receivable, net
Inventory
Prepaid expenses and other current assets
Total current assets
Property, plant, and equipment, net
Operating lease assets
Intangible assets, net
Goodwill
Deferred tax assets
Other assets
Total assets
Liabilities and stockholders’ equity
Accounts payable
Accrued liabilities
Current tax liabilities
Other current liabilities
Total current liabilities
Long-term liabilities:
Capital lease obligations
Build-to-suit financing obligation
Finance lease liabilities
Operating lease liabilities
Other liabilities
Total long-term liabilities
Total liabilities
Stockholders’ equity:
Ordinary shares par value £0.001; 378,505,496 shares outstanding as of March 31, 2021; 375,196,172 shares outstanding as of December 31, 2020
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Total stockholders’ equity
Total liabilities and stockholders’ equity

Comments